AI assistant
Indaptus Therapeutics, Inc. — Capital/Financing Update 2021
Sep 28, 2021
35475_rns_2021-09-28_b74d810c-89ab-4688-bcb1-369ef8b831de.zip
Capital/Financing Update
Open in viewerOpens in your device viewer
CORRESP 1 filename1.htm
Indaptus Therapeutics, Inc.
3 Columbus Circle, 15 th Floor
New York, NY 10019
September 28, 2021
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: |
|---|
| Registration |
| Statement on Form S-1 |
| File |
| No. 333-259771 |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Indaptus Therapeutics, Inc. (the “Registrant”) hereby respectfully requests that the effectiveness of the Registration Statement on Form S-1 (File No. 333-259771) of the Registrant (the “Registration Statement”) be accelerated so that it will be declared effective at 1:00 p.m., Eastern Time, on September 29, 2021 or as soon thereafter as may be practicable.
The Registrant hereby acknowledges that:
| ● | should
the Securities and Exchange Commission (the “Commission”) or the staff, acting
pursuant to delegated authority, declare the Registration Statement effective, it does not
foreclose the Commission from taking any action with respect to the Registration Statement; |
| --- | --- |
| ● | the
action of the Commission or the staff, acting pursuant to delegated authority, in declaring
the Registration Statement effective, does not relieve the Registrant from its full responsibility
for the adequacy and accuracy of the disclosure in the filing; and |
| ● | the
Registrant may not assert staff comments and the declaration of effectiveness as a defense
in any proceeding initiated by the Commission or any person under the federal securities
laws of the United States. |
The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, McDermott Will & Emery LLP, by calling Ze’-ev Eiger at (212) 547-5470. The Registrant hereby authorizes Mr. Eiger to orally modify or withdraw this request for acceleration.
| Very
truly yours, | |
| --- | --- |
| INDAPTUS
THERAPEUTICS, INC. | |
| By: | /s/
Jeffrey A. Meckler |
| Name: | Jeffrey
A. Meckler |
| Title: | Chief
Executive Officer |
Field: Page; Sequence: 1; Options: Last
Field: /Page